scholarly journals Test and Treat in Washington, DC: Evaluating the Costs and Benefits of a Comprehensive Strategy to Fight HIV/AIDS

2014 ◽  
Vol 21 ◽  
pp. 7
Author(s):  
Estelle R. Raimondo

This paper assesses the economic implications of an innovative approach to preventing the spread of HIV/AIDS in Washington, DC. “Test & Treat” is premised on the idea that the epidemic can ultimately be eliminated by testing people widely and regularly and by putting all infected persons on antiretroviral medicines upon diagnosis. The relative costs and benefits of Test & Treat are quantified, monetized, and compared to the status quo, which can be characterized as a ‘test and wait’ approach. This cost-benefit analysis concludes that under a plausible set of circumstances, and with a conservative estimate of the number of infections averted, the benefits of Test & Treat in Washington, DC would outweigh the costs of implementation.

1998 ◽  
Vol 3 (2) ◽  
pp. 221-262 ◽  
Author(s):  
NICK HANLEY

One of the first lessons that students of cost-benefit analysis (CBA) learn is to ask whether projects or policies which they are studying generate additional benefits or costs, relative to the status quo. They are also told to be very careful in defining the project/policy which is the subject of their analysis. In my view, the ecological concept of resilience fails the CBA test, when applied to the study of economic and social systems, because it offers no additional insights to those we have already, and appears to be poorly defined.


1993 ◽  
Vol 9 (2) ◽  
pp. 229-252 ◽  
Author(s):  
Julianne Nelson

How do economists persuade their readers that one policy is superior to another? A glance at the literature on welfare economics quickly provides the answer to this question: Economists enter policy debates armed with mathematical models, evaluating options on the basis of their consequences. Economists typically classify a policy change as a welfare (or “potential Pareto”) improvement with respect to the status quo if the gain realized by the winners exceeds the harm sustained by the losers. The best policy becomes the one that generates the highest net benefit.


2002 ◽  
Vol 22 (1_suppl) ◽  
pp. 58-66 ◽  
Author(s):  
Faruque Ahmed ◽  
Elamin E. Elbasha ◽  
Betsy L. Thompson ◽  
Jeffrey R. Harris ◽  
Vishnu-Priya Sneller

Objectives Measurement of the quality of care provided by managed care organizations (MCOs) has achieved national prominence, though there is controversy regarding its value. This article assesses the economic implications of a new Health Plan Employer Data and Information Set (HEDIS®) measure for pneumococcal vaccination. Methods A Markov decision model, with Monte Carlo simulations, was utilized to conduct a cost-benefit analysis of annual HEDIS-associated interventions, which were repeated for 5 consecutive years, in an average Medicare MCO, using a societal perspective and a 3% annual discount rate. Results Compared with the status quo, the HEDIS intervention will be cost saving 99.8% of the time, with an average net savings of $3.80 per enrollee (95% probability interval: $0.73–$6.87). Conclusions The new HEDIS measure will save societal dollars. This type of analysis is essential if performance measurement is to become a legitimate part of our health care landscape.


2007 ◽  
pp. 70-84 ◽  
Author(s):  
E. Demidova

This article analyzes definitions and the role of hostile takeovers at the Russian and European markets for corporate control. It develops the methodology of assessing the efficiency of anti-takeover defenses adapted to the conditions of the Russian market. The paper uses the cost-benefit analysis, where the costs and benefits of the pre-bid and post-bid defenses are compared.


2020 ◽  
Vol 13(62) (2) ◽  
pp. 157-166
Author(s):  
Ștefan Bulboacă ◽  
Ovidiu Mircea Țierean

"This paper aims to evaluate the economic effects that the Romanian National Gambling Office has over the gambling industry and to determine whether this public institution brings enough benefits to cover the costs. The aim of the research was to gather information about the Romanian gambling industry, the way that this industry is managed and to make a comparison between its societal costs and benefits. "


2017 ◽  
Vol 33 (S1) ◽  
pp. 75-76
Author(s):  
Paul van Gils ◽  
Eelco Over ◽  
Anita Suijkerbuijk ◽  
Joran Lokkerbol ◽  
Ardine de Wit

INTRODUCTION:Due to their chronic nature and high prevalence, alcohol and cannabis addiction leads to a significant (disease) burden and high costs, both for those involved and for society. The latter includes effects on health care, quality of life, employment, criminality, education, social security, violence in the public and private domain, and traffic accidents. In the Netherlands, a considerable number of people with an alcohol or cannabis addiction currently do not receive addiction care. Cognitive Behavioral Therapy (CBT) is effective as a treatment for both alcohol and cannabis addiction and is widely used in specialized addiction care centers. This social cost-benefit analysis (SCBA) models costs and benefits of increasing the uptake of CBT for persons with an alcohol addiction and for adolescents with a cannabis addiction, taking into account a wide range of social costs and effects (1).METHODS:The method follows general Dutch guidance for performing SCBA. A literature search was conducted to evaluate efficacy of CBT for alcohol and cannabis dependence. In addition, the social costs of alcohol and cannabis addiction for society were mapped, and the costs of enhancing the uptake of CBT were explored. Costs and benefits of increased uptake of CBT for different social domains were modeled for a ten year period, and compared with current (unchanged) uptake during this period. Compliance problems (about 50 percent of clients do not finish CBT) and fall-back to addiction behavior (decrease of effects of CBT over time) were taken into account in model estimations.RESULTS:Per client treated with CBT, the estimated benefits to society are EUR10,000-14,000 and EUR9,700-13,000, for alcohol and cannabis addiction, respectively. These benefits result from reduced morbidity and mortality, improved quality of life, higher productivity, fewer traffic accidents, and fewer criminal activities.CONCLUSIONS:This SCBA shows that not only treated clients but also society will benefit from an increase in people treated with CBT in specialized addiction care centers.


PEDIATRICS ◽  
1985 ◽  
Vol 75 (4) ◽  
pp. 798-799
Author(s):  
DONALD N. MANGRAVITE

To the Editor.— I would like to commend Walker and colleagues1 for their comprehensive examination of the costs and benefits of neonatal intensive care for infants weighing less than 1,000 grams. However, examining only one group of infants served by a tertiary neonatal intensive care unit (NICU) can be misleading. By definition, a tertiary level NICU is designed to provide a broad range of services to infants with a wide variety of illnesses. As is true for any system expected to provide a broad range of services, some services will result in a more favorable cost-benefit ratio than others.


2014 ◽  
Vol 3 (5) ◽  
pp. 47
Author(s):  
Sanni Yaya ◽  
Xiaonan Li

This paper offers a general guide on how to conduct a proper economic analysis for community-based intervention projects. Identification and quantification of costs and benefits are the focus of the cost benefit analysis. We categorize costs and benefits from human and physical perspectives and pay special attention to the measures of saving human lives accompanied by the proposed calculation methods. We recommend net present value and benefit-cost ratio as the criteria to assess projects and highlight some challenges remaining in the analysis.


2011 ◽  
Vol 6 (1) ◽  
pp. 25-32
Author(s):  
Jill S. Rumberger ◽  
Christopher S. Hollenbeak

AbstractObjectives:To determine whether the cost of a statewide smoking cessation program in Pennsylvania could be justified by the benefits.Methods:A cost-benefit analysis of statewide access to smoking cessation programs. We compared three treatment alternatives, both with and without counselling: nicotine replacement therapy, bupropion and varenicline.Results:While the retail price of a pack of cigarettes in Pennsylvania is on average US$4.72, the combined medical costs and productivity losses in Pennsylvania attributable to each pack of cigarettes sold are approximately US$23.78 per pack of cigarettes. The ratio of benefits to cost varied from US$0.97 to US$2.76 saved per dollar spent on smoking cessation programs, depending upon the type of intervention.Conclusions:For most smoking cessation treatments, the benefits of a statewide smoking cessation program in Pennsylvania would greatly outweigh its costs.


Sign in / Sign up

Export Citation Format

Share Document